(Q72227326)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:5725012%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

title

[On a new hypertensive agent with predominant central action, 2-(2,6-dichlorophenylamino)-2-imidazolinhydrochloride (St 155)] (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:5725012%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

author name string

P A van Zwieten

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:5725012%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

publication date

1 January 1968

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:5725012%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

published in

Klinische Wochenschrift

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:5725012%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

volume

46

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:5725012%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:5725012%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

page(s)

77-80

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:5725012%20AND%20SRC:MED&resulttype=core&format=json

[First clinical experiences with a new hypotensive substance in severe forms of hypertension]

25 October 2019

cites work

1 reference

12 December 2020

[Continuous automatic recording of blood pressure after administration of a new antihypertensive substance]

1 reference

12 December 2020

[Biochemical studies on the resorption, distribution and excretion of 2-(2,6-dichlorophenylamino)-2-imidazoline-hydrochloride in the rat]

1 reference

12 December 2020

Clinical experiences with the new antihypertensive agent Catapresan

1 reference

12 December 2020

[On the mechanism of action of a new antihypertensive substance with imidazoline structure]

1 reference

12 December 2020

Blood circulation studies with 2-(2,6-dichlorphenylamino)-2-imidazoline hydrochloride

1 reference

12 December 2020

First clinical experiences with a blood pressure lowering imidazole compound

1 reference

12 December 2020

ECG studies following oral administration of a new antihypertensive substance (Catapresan)

1 reference

12 December 2020

[Single dose studies on the effect of 2-(2,6-dichlorphenylamino)-2-imidazoline-hydrochloride on blood pressure and pulse in hypertonic subjects and on its tolerance]

1 reference

12 December 2020

[Results of toxicologic and teratologic animal studies with 2-(2,6-dichlorophenylamino)-2-imidazoline-hydrochloride]

1 reference

12 December 2020

Acute hypotensive action of 2-(2,6-dichlorophenylamino)- 2-imidazoline hydrochloride (St 155) after infusion into the cat's vertebral artery

1 reference

12 December 2020

[Cerebral hemodynamics under the effect of 2-(2,6-dichlorphenylamino)-2-imidazoline hydrochloride]

1 reference

12 December 2020

[Experimental study of kidney hemodynamics and the behavior of electrolytes after a single administration of 2-(2,6-dichlorphenylamino)-2-imidazoline hydrochloride]

1 reference

12 December 2020

Comparative studies on the adrenergic neuro-hormonal control of resistance and capacitance blood vessels in the cat

1 reference

12 December 2020

[First observations on an antihypertensive effect of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride in man]

1 reference

12 December 2020

[Effect of 2-(2,6-dichlorophenylamino)-2-imidazoline-hydrochloride on the blood flow of the extremities, blood pressure and venous capacity in normotensive subjects]

1 reference

12 December 2020

[Central effect of reserpine on the circulatory reflexes of the carotid sinus]

1 reference

12 December 2020

Clinical and clinical-experimental studies with a new blood pressure lowering substance: dichlorophenylaminoimidazoline

1 reference

12 December 2020

[Pharmacological effects of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride, a new, antihypertensive substance]

1 reference

12 December 2020

[Critical considerations on the method of action of 2-(2,6-dichlorophenylamino)-2-imidazoline-hydrochloride]

1 reference

12 December 2020

Effect of a new hypotensive drug, ST155, on the systemic circulation.

1 reference

12 December 2020

[Clinical and experimental study with the new blood pressure depressant 2-(2,6-dichlorphenylamino)-2-imidazole-hydrochloride]

1 reference

12 December 2020

[The effect of an imidazole derivative on arterial blood pressure, hemodynamics and ventilation]

1 reference

12 December 2020

Behavior of psyche, blood pressure and pulse rate following administration of the antihypertensive agent "Catapresan"

1 reference

12 December 2020

[Therapeutic examination and studies on renal function with a new antihypertensive agent (St 155)]

1 reference

12 December 2020

Central hypotensive effect of alpha-methyldopa.

1 reference

12 December 2020

Ophthalmological studies with dichlorophenylaminoimidazoline with special regard to its effect on intraocular pressure

1 reference

12 December 2020

The effect of 2-(2,6-dichlorophenylamino)-2-imidazoline-hydrochloride on the EEG arousal reaction in rabbits

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01747472

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:5725012%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

1 reference